(Q47587104)

English

Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulati

scientific article published in June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulati (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

Bordetella pertussis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pertussis vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Daniel Rabczenko

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

Janusz Slusarczyk

6

object named as

Janusz Slusarczyk

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

author name string

Anna Gzyl

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

Ewa Augustynowicz

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

Grzegorz Gniadek

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

Grazyna Dulny

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

22

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

17-18

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

2122-2128

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Masseteric silent period in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Pertussis in Poland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Impact of anti-vaccine movements on pertussis control: the untold story

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Global DTP manufacturing capacity and capability. Status report: January 1995.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.006

7 January 2021

Identifiers

10.1016/J.VACCINE.2003.12.006

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15149768

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47587104&oldid=2124765821"